creatine has been researched along with HIV Coinfection in 46 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Proteinuria was observed in 27% of 153 patients taking tenofovir for more than 1 year." | 7.79 | Tenofovir-associated proteinuria. ( Bartlett, H; Gibson, A; Kelly, MD; Patten, J; Rowling, D, 2013) |
| "5 Tesla magnetic resonance scanner in HIV-infected subjects as follows: 12 subjects before (group 1) and after intensification of antiretroviral therapy with maraviroc (group 2) and 13 subjects with acute viral hepatitis C (HCV) co-infection (group 3)." | 3.81 | Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts. ( Garvey, L; Rojas, JH; Taylor-Robinson, S; Vigneswaran, S; Winston, A, 2015) |
| "Proteinuria was observed in 27% of 153 patients taking tenofovir for more than 1 year." | 3.79 | Tenofovir-associated proteinuria. ( Bartlett, H; Gibson, A; Kelly, MD; Patten, J; Rowling, D, 2013) |
| "In absence of HIV infection, or concomitant treatment, short-term exposure to T20 or RAL in healthy adult volunteers did not lead to any indicative changes in toxicity markers thus presuming the safe profile of both drugs." | 2.90 | Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers. ( Arnaiz, JA; Barroso, S; Blanco, JL; Carné, X; Garrabou, G; Gatell, JM; González-Segura, À; Larousse, M; Lazzari, E; Llopis, J; Loncà, M; Mallolas, J; Manriquez, M; Martínez, E; Miró, O; Morén, C; Riba, N; Santana, G, 2019) |
| " Treatment began with a loading dose of 20 g/day or an equivalent number of placebo capsules for 5 days, followed by maintenance dosing of 4." | 2.74 | Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study. ( Dasilva, M; Doyle, JW; Kent-Braun, JA; Khatami, H; Mulligan, K; Sakkas, GK; Schambelan, M; Schleich, T, 2009) |
| "Fatigue is among the most common symptoms reported by HIV-infected individuals." | 1.37 | Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals. ( Clifford, D; Deng, L; Ernst, T; Evans, SR; Schifitto, G; Yeh, TM; Zhong, J, 2011) |
| " Utilizing resources to assess renal function prior to initiation of antiretrovirals in order to identify those likely to benefit from dosage adjustment is justified." | 1.34 | Renal disease in an antiretroviral-naïve HIV-infected outpatient population in Western Kenya. ( Aubrey, RW; Goldman, M; Gupta, SK; Kipruto, K; Muloma, E; Owino-Ong'or, W; Shen, J; Sidle, J; Wools-Kaloustian, K; Zwickl, BE, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (17.39) | 18.2507 |
| 2000's | 16 (34.78) | 29.6817 |
| 2010's | 18 (39.13) | 24.3611 |
| 2020's | 4 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Bertran-Cobo, C | 1 |
| Wedderburn, CJ | 1 |
| Robertson, FC | 3 |
| Subramoney, S | 1 |
| Narr, KL | 1 |
| Joshi, SH | 1 |
| Roos, A | 1 |
| Rehman, AM | 1 |
| Hoffman, N | 1 |
| Zar, HJ | 1 |
| Stein, DJ | 1 |
| Donald, KA | 1 |
| Dos Santos Quaresma, MV | 1 |
| Maria de Melo, C | 1 |
| Lima Ribeiro, SM | 1 |
| Boban, J | 2 |
| Thurnher, MM | 1 |
| Brkic, S | 2 |
| Lendak, D | 2 |
| Bugarski Ignjatovic, V | 1 |
| Todorovic, A | 1 |
| Kozic, D | 2 |
| Chelala, L | 1 |
| O'Connor, EE | 1 |
| Barker, PB | 2 |
| Zeffiro, TA | 1 |
| Graham, AS | 1 |
| Holmes, MJ | 2 |
| Little, F | 2 |
| Dobbels, E | 1 |
| Cotton, MF | 2 |
| Laughton, B | 2 |
| van der Kouwe, A | 1 |
| Meintjes, EM | 2 |
| Randall, SR | 1 |
| van der Kouwe, AJW | 1 |
| Barroso, S | 1 |
| Morén, C | 1 |
| González-Segura, À | 1 |
| Riba, N | 1 |
| Arnaiz, JA | 1 |
| Manriquez, M | 1 |
| Santana, G | 1 |
| Blanco, JL | 1 |
| Larousse, M | 1 |
| Loncà, M | 1 |
| Lazzari, E | 1 |
| Llopis, J | 1 |
| Mallolas, J | 1 |
| Miró, O | 1 |
| Carné, X | 1 |
| Gatell, JM | 1 |
| Garrabou, G | 1 |
| Martínez, E | 1 |
| Li, CX | 1 |
| Zhang, X | 1 |
| Komery, A | 1 |
| Li, Y | 1 |
| Mao, H | 1 |
| Herndon, JG | 1 |
| Novembre, FJ | 1 |
| Winston, A | 3 |
| Puls, R | 2 |
| Kerr, SJ | 2 |
| Duncombe, C | 2 |
| Li, P | 1 |
| Gill, JM | 2 |
| Ramautarsing, R | 1 |
| Taylor-Robinson, SD | 2 |
| Emery, S | 2 |
| Cooper, DA | 2 |
| Vigneswaran, S | 1 |
| Rojas, JH | 1 |
| Garvey, L | 1 |
| Taylor-Robinson, S | 1 |
| Van Dalen, YW | 1 |
| Blokhuis, C | 1 |
| Cohen, S | 1 |
| Ter Stege, JA | 1 |
| Teunissen, CE | 1 |
| Kuhle, J | 1 |
| Kootstra, NA | 1 |
| Scherpbier, HJ | 1 |
| Kuijpers, TW | 1 |
| Reiss, P | 1 |
| Majoie, CBLM | 1 |
| Caan, MWA | 1 |
| Pajkrt, D | 1 |
| Bairwa, D | 1 |
| Kumar, V | 1 |
| Vyas, S | 1 |
| Das, BK | 1 |
| Srivastava, AK | 1 |
| Pandey, RM | 1 |
| Sharma, SK | 1 |
| Jagannathan, NR | 1 |
| Sinha, S | 1 |
| Iqbal, Z | 1 |
| Wilson, NE | 1 |
| Keller, MA | 3 |
| Michalik, DE | 1 |
| Church, JA | 1 |
| Nielsen-Saines, K | 1 |
| Deville, J | 1 |
| Souza, R | 1 |
| Brecht, ML | 1 |
| Thomas, MA | 2 |
| Turkulov, V | 1 |
| Ostojic, J | 1 |
| Semnic, R | 1 |
| Paul, RH | 1 |
| Ernst, T | 4 |
| Brickman, AM | 1 |
| Yiannoutsos, CT | 2 |
| Tate, DF | 1 |
| Cohen, RA | 1 |
| Navia, BA | 1 |
| Sakkas, GK | 1 |
| Mulligan, K | 1 |
| Dasilva, M | 1 |
| Doyle, JW | 1 |
| Khatami, H | 1 |
| Schleich, T | 1 |
| Kent-Braun, JA | 1 |
| Schambelan, M | 1 |
| Mohamed, MA | 1 |
| Lentz, MR | 1 |
| Lee, V | 1 |
| Halpern, EF | 1 |
| Sacktor, N | 1 |
| Selnes, O | 1 |
| Pomper, MG | 1 |
| Li, PC | 1 |
| Petoumenos, K | 1 |
| Schifitto, G | 1 |
| Deng, L | 1 |
| Yeh, TM | 1 |
| Evans, SR | 1 |
| Zhong, J | 1 |
| Clifford, D | 1 |
| Duprez, DA | 1 |
| Neuhaus, J | 1 |
| Tracy, R | 1 |
| Kuller, LH | 1 |
| Deeks, SG | 1 |
| Orkin, C | 1 |
| Stoehr, A | 1 |
| Woolley, IJ | 1 |
| Neaton, JD | 1 |
| Letendre, SL | 2 |
| Zheng, JC | 1 |
| Kaul, M | 1 |
| Ellis, RJ | 1 |
| Taylor, MJ | 2 |
| Marquie-Beck, J | 1 |
| Navia, B | 1 |
| Prado, PT | 1 |
| Escorsi-Rosset, S | 1 |
| Cervi, MC | 1 |
| Santos, AC | 1 |
| Kelly, MD | 1 |
| Gibson, A | 1 |
| Bartlett, H | 1 |
| Rowling, D | 1 |
| Patten, J | 1 |
| Bladowska, J | 1 |
| Zimny, A | 1 |
| Kołtowska, A | 1 |
| Szewczyk, P | 1 |
| Knysz, B | 1 |
| Gąsiorowski, J | 1 |
| Furdal, M | 1 |
| Sąsiadek, MJ | 1 |
| Venkatraman, TN | 1 |
| Thomas, A | 1 |
| Deveikis, A | 2 |
| LoPresti, C | 1 |
| Hayes, J | 2 |
| Berman, N | 1 |
| Walot, I | 1 |
| Padilla, S | 1 |
| Johnston-Jones, J | 1 |
| Chang, L | 2 |
| St Hillaire, C | 1 |
| Conant, K | 1 |
| Katz-Brull, R | 1 |
| Lenkinski, RE | 3 |
| Du Pasquier, RA | 1 |
| Koralnik, IJ | 1 |
| Pfefferbaum, A | 1 |
| Adalsteinsson, E | 1 |
| Sullivan, EV | 1 |
| Nelson, JA | 1 |
| Dou, H | 1 |
| Ellison, B | 1 |
| Uberti, M | 1 |
| Xiong, H | 1 |
| Anderson, E | 1 |
| Mellon, M | 1 |
| Gelbard, HA | 1 |
| Boska, M | 1 |
| Gendelman, HE | 1 |
| Seminari, E | 1 |
| Castagna, A | 1 |
| Soldarini, A | 1 |
| Galli, L | 1 |
| Fusetti, G | 1 |
| Dorigatti, F | 1 |
| Hasson, H | 1 |
| Danise, A | 1 |
| Guffanti, M | 1 |
| Lazzarin, A | 1 |
| Rubinacci, A | 1 |
| Le Moing, V | 1 |
| Chêne, G | 1 |
| Spire, B | 1 |
| Raffi, F | 1 |
| Leport, C | 1 |
| Schuff, N | 1 |
| Meyerhoff, DJ | 2 |
| Mueller, S | 1 |
| Chao, L | 1 |
| Sacrey, DT | 1 |
| Laxer, K | 1 |
| Weiner, MW | 2 |
| Gabis, L | 1 |
| Belman, A | 1 |
| Huang, W | 1 |
| Milazzo, M | 1 |
| Nachman, S | 1 |
| Schweinsburg, BC | 1 |
| Alhassoon, OM | 1 |
| Gongvatana, A | 1 |
| Brown, GG | 1 |
| Young-Casey, C | 1 |
| Grant, I | 1 |
| Roc, AC | 1 |
| Ances, BM | 1 |
| Chawla, S | 1 |
| Korczykowski, M | 1 |
| Wolf, RL | 1 |
| Kolson, DL | 1 |
| Detre, JA | 1 |
| Poptani, H | 1 |
| Wools-Kaloustian, K | 1 |
| Gupta, SK | 1 |
| Muloma, E | 1 |
| Owino-Ong'or, W | 1 |
| Sidle, J | 1 |
| Aubrey, RW | 1 |
| Shen, J | 1 |
| Kipruto, K | 1 |
| Zwickl, BE | 1 |
| Goldman, M | 1 |
| Banakar, S | 1 |
| Watzl, JQ | 1 |
| Vion-Dury, J | 1 |
| Confort-Gouny, S | 1 |
| Nicoli, F | 1 |
| Dhiver, C | 1 |
| Gastaut, JA | 1 |
| Gastaut, JL | 1 |
| Cozzone, PJ | 1 |
| Wilkinson, ID | 2 |
| Paley, M | 2 |
| Chong, WK | 2 |
| Sweeney, BJ | 1 |
| Shepherd, JK | 1 |
| Kendall, BE | 2 |
| Hall-Craggs, MA | 2 |
| Harrison, MJ | 1 |
| Sweeney, B | 1 |
| Shepard, JK | 1 |
| Beecham, M | 1 |
| Miller, RF | 1 |
| Weller, IV | 1 |
| Fein, G | 1 |
| Jarvik, JG | 1 |
| Saykin, AJ | 1 |
| Jaans, A | 1 |
| Frank, I | 2 |
| López-Villegas, D | 1 |
| Simone, IL | 1 |
| Federico, F | 1 |
| Tortorella, C | 1 |
| Andreula, CF | 1 |
| Zimatore, GB | 1 |
| Giannini, P | 1 |
| Angarano, G | 1 |
| Lucivero, V | 1 |
| Picciola, P | 1 |
| Carrara, D | 1 |
| Bellacosa, A | 1 |
| Livrea, P | 1 |
| March, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Ergogenic Effects of Creatine Supplementation in HIV Infection[NCT00484627] | Phase 2 | 43 participants (Actual) | Interventional | 2001-08-31 | Completed | ||
| A Randomised, Open-label, 96-week Study Comparing the Safety and Efficacy of Three Different Combination Antiretroviral Regimens as Initial Therapy for HIV Infection.[NCT00335322] | Phase 4 | 329 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| Phase II, Placebo-Controlled, Double-Blind Study of the Selegiline Transdermal System (STS) in the Treatment of HIV-Associated Cognitive Impairment[NCT00013585] | Phase 2 | 127 participants (Actual) | Interventional | Completed | |||
| A Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)[NCT00027352] | 6,000 participants | Observational | Completed | ||||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00335322)
Timeframe: 144 weeks
| Intervention | log copies/mL (Mean) |
|---|---|
| TDF/FTC+EFV | -2.77 |
| TDF/FTC+ r/ATV | -2.88 |
| TDF/FTC + AZT+ABC | -2.54 |
(NCT00335322)
Timeframe: 48 weeks
| Intervention | log copies/mL (Mean) |
|---|---|
| TDF/FTC+EFV | -2.59 |
| TDF/FTC+r/ATV | -2.69 |
| TDF/FTC+AZT+ABC | -2.39 |
3 reviews available for creatine and HIV Coinfection
| Article | Year |
|---|---|
Effect of proteins, amino acids, and other nitrogenated supplements on the skeletal muscle mass in people living with HIV (PLWH): A systematic review.
Topics: Amino Acids; Creatine; Dietary Supplements; HIV Infections; Humans; Muscle, Skeletal | 2022 |
Meta-analysis of brain metabolite differences in HIV infection.
Topics: Aspartic Acid; Brain; Choline; Creatine; HIV Infections; Humans; Inositol; Magnetic Resonance Imagin | 2020 |
N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.
Topics: Aging; Alcoholism; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Brain Injuries; | 2006 |
6 trials available for creatine and HIV Coinfection
| Article | Year |
|---|---|
Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers.
Topics: Adult; Alanine Transaminase; Anti-Retroviral Agents; Creatine; Enfuvirtide; Healthy Volunteers; HIV | 2019 |
Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART.
Topics: Anti-HIV Agents; Aspartic Acid; Brain Chemistry; Cognition; Creatine; Drug Therapy, Combination; HIV | 2015 |
Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Body Composition; Creatine; Double-Blind Method; HIV Infections; Humans; Male; Middle Aged; M | 2009 |
Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.
Topics: AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aspartic Acid; Brain | 2010 |
Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.
Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brain; Brain C | 2004 |
Side effects and complications. Creatine flunks a test.
Topics: Adult; Body Composition; Creatine; HIV Infections; Humans; Male; Placebos; Weight Lifting | 2005 |
37 other studies available for creatine and HIV Coinfection
| Article | Year |
|---|---|
A Neurometabolic Pattern of Elevated Myo-Inositol in Children Who Are HIV-Exposed and Uninfected: A South African Birth Cohort Study.
Topics: Birth Cohort; Child; Child, Preschool; Cohort Studies; Creatine; Female; HIV Infections; Humans; Ino | 2022 |
Neurometabolic Remodeling in Chronic Hiv Infection: a Five-Year Follow-up Multi-Voxel Mrs Study.
Topics: Adult; Algorithms; Anti-HIV Agents; Aspartic Acid; Brain; Brain Neoplasms; Cell Communication; Cell | 2019 |
MRS suggests multi-regional inflammation and white matter axonal damage at 11 years following perinatal HIV infection.
Topics: Anti-Retroviral Agents; Aspartic Acid; Child; Creatine; Female; HIV Infections; Humans; Inflammation | 2020 |
Longitudinal increases of brain metabolite levels in 5-10 year old children.
Topics: Aspartic Acid; Brain; Child; Child, Preschool; Creatine; Female; Glutamic Acid; HIV Infections; Huma | 2017 |
Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb.
Topics: Animals; Aspartic Acid; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Choline; Corpus Stri | 2014 |
Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
Topics: Adult; Antiretroviral Therapy, Highly Active; Aspartic Acid; Basal Ganglia; Brain; Brain Chemistry; | 2015 |
Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.
Topics: Adolescent; AIDS Dementia Complex; Aspartic Acid; Brain; CD4 Lymphocyte Count; Child; Choline; Cogni | 2016 |
Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.
Topics: Adult; Aspartic Acid; Basal Ganglia; Case-Control Studies; Choline; Creatine; Dipeptides; Female; Fr | 2016 |
Pilot Assessment of Brain Metabolism in Perinatally HIV-Infected Youths Using Accelerated 5D Echo Planar J-Resolved Spectroscopic Imaging.
Topics: Adolescent; AIDS Dementia Complex; Algorithms; Anti-HIV Agents; Aspartic Acid; Brain; Case-Control S | 2016 |
HIV-associated neurodegeneration and neuroimmunity: multivoxel MR spectroscopy study in drug-naïve and treated patients.
Topics: Adult; AIDS Dementia Complex; Aspartic Acid; Biomarkers; Brain; Case-Control Studies; Choline; Creat | 2017 |
Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV.
Topics: Adult; Affect; Aspartic Acid; Choline; Cognition Disorders; Creatine; Female; HIV Infections; Humans | 2008 |
Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia.
Topics: Adult; AIDS Dementia Complex; Analysis of Variance; Aspartic Acid; Case-Control Studies; Chi-Square | 2010 |
Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.
Topics: Adult; Biomarkers; Brain; CD4 Lymphocyte Count; Creatine; Double-Blind Method; Fatigue; Female; HIV | 2011 |
N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Creatine; Female; HIV Infections; HIV-1; Human | 2011 |
Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals.
Topics: Adult; Aspartic Acid; CD4 Lymphocyte Count; Cerebrum; Chemokines; Cohort Studies; Creatine; Female; | 2011 |
Image evaluation of HIV encephalopathy: a multimodal approach using quantitative MR techniques.
Topics: Brain; Brain Diseases; Child; Child, Preschool; Choline; Creatine; Female; HIV Infections; Humans; M | 2011 |
Tenofovir-associated proteinuria.
Topics: Adenine; Anti-HIV Agents; Creatine; Female; HIV Infections; Humans; Male; Middle Aged; Organophospho | 2013 |
Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
Topics: Adult; Analysis of Variance; Anti-HIV Agents; Aspartic Acid; Brain; Case-Control Studies; Choline; C | 2013 |
Altered neurometabolite development in HIV-infected children: correlation with neuropsychological tests.
Topics: Adolescent; Age Factors; Aspartic Acid; Brain; Brain Chemistry; CD4 Lymphocyte Count; Child; Choline | 2004 |
Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy.
Topics: Adult; Aspartic Acid; Cerebellum; Cerebral Cortex; Choline; Creatine; Disease Progression; Female; H | 2004 |
Cortical NAA deficits in HIV infection without dementia: influence of alcoholism comorbidity.
Topics: Adult; Alcoholism; Aspartic Acid; Brain Mapping; Case-Control Studies; Cerebral Cortex; Choline; Com | 2005 |
Coregistration of quantitative proton magnetic resonance spectroscopic imaging with neuropathological and neurophysiological analyses defines the extent of neuronal impairments in murine human immunodeficiency virus type-1 encephalitis.
Topics: AIDS Dementia Complex; Animals; Aspartic Acid; Brain Mapping; Calcium-Binding Proteins; Capsid Prote | 2005 |
Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
Topics: Adult; Age Factors; Alkaline Phosphatase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bi | 2005 |
[Outcome of HIV-infected patients after 5 years of antiretroviral therapy including a protease inhibitor: the Aproco/Copilote Cohort].
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Clinical Trials as Topic; Cohort | 2005 |
Clinical and imaging study of human immunodeficiency virus-1-infected youth receiving highly active antiretroviral therapy: pilot study using magnetic resonance spectroscopy.
Topics: Adolescent; Antiretroviral Therapy, Highly Active; Aspartic Acid; Brain; Child; Choline; Creatine; F | 2006 |
Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy.
Topics: Adult; Aspartic Acid; Basal Ganglia; Brain; Brain Diseases; CD4 Lymphocyte Count; Central Nervous Sy | 2007 |
Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy.
Topics: Adult; AIDS Dementia Complex; Antiretroviral Therapy, Highly Active; Aspartic Acid; Atrophy; Biomark | 2007 |
Renal disease in an antiretroviral-naïve HIV-infected outpatient population in Western Kenya.
Topics: Adult; Anti-Retroviral Agents; Cohort Studies; Creatine; Female; HIV Infections; Humans; Kenya; Kidn | 2007 |
Two-dimensional 1H MR spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Child; Choline; Creatine; gamma-Aminobutyric Acid; HIV Infe | 2008 |
Localized brain proton MRS metabolic patterns in HIV-related encephalopathies.
Topics: AIDS Dementia Complex; Aspartic Acid; Brain; Choline; Creatine; HIV Infections; Humans; Magnetic Res | 1994 |
Proton spectroscopy in HIV infection: relaxation times of cerebral metabolites.
Topics: Adult; Aspartic Acid; Brain; CD4 Lymphocyte Count; Choline; Creatine; Female; HIV Infections; HIV Se | 1994 |
Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings.
Topics: Adult; Aspartic Acid; Brain; CD4-Positive T-Lymphocytes; Choline; Creatine; Female; HIV Infections; | 1993 |
Deep gray matter structures in HIV infection: a proton MR spectroscopic study.
Topics: Adult; AIDS Dementia Complex; Aspartic Acid; Basal Ganglia; Brain; Cerebral Ventricles; Choline; Cor | 1996 |
Proton spectroscopy in asymptomatic HIV-infected adults: initial results in a prospective cohort study.
Topics: Adult; Amino Acids; Brain; Brain Diseases; CD4 Lymphocyte Count; Choline; Creatine; Female; HIV Infe | 1996 |
Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy.
Topics: Adult; AIDS Dementia Complex; Brain Chemistry; Creatine; Female; Frontal Lobe; HIV Infections; HIV-1 | 1997 |
Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.
Topics: Adolescent; Adult; AIDS Dementia Complex; Aspartic Acid; Case-Control Studies; Choline; Creatine; Di | 1998 |
Muscle up.
Topics: Creatine; HIV Infections; Humans; Muscle, Skeletal; Weight Gain | 1998 |